flavonoid
natur
occur
polyphenol
biomolecul
wide
found
plant
respons
wide
varieti
biolog
function
pharmacolog
properti
flavonoid
includ
antioxid
antiinflammatori
anticanc
antimicrobi
immunomodulatori
function
compound
identifi
flavonoid
base
basic
structur
consist
divid
sever
class
flavonol
flavanon
isoflavon
flavon
anthocyanidin
due
wide
rang
biolog
activ
exhibit
flavonoid
becom
molecul
interest
natur
drug
discoveri
research
review
antivir
mechan
flavonoid
mainli
enteroviru
discuss
provid
evidencebas
efficaci
antivir
properti
research
carri
plant
use
tradit
medicin
differ
part
world
mani
natur
compound
variou
chemic
class
identifi
potenti
therapeut
agent
sever
flavonoid
studi
evalu
antivir
potenti
exampl
quercetin
quercitrin
first
demonstr
cut
et
al
prophylact
inhibit
rabi
viru
mice
moreov
quercetin
found
exhibit
antivir
activ
vesicular
stomat
viru
vsv
activ
macrophag
biolog
activ
compon
elderberri
extract
dihydromyricetin
tetraomethyl
quercetin
found
inhibit
influenza
viru
vitro
like
bind
viral
mannoserich
hemagglutinin
domain
import
viru
enter
host
cell
mechanist
studi
later
show
abl
inhibit
neuraminidas
activ
influenza
viru
interact
subunit
hemagglutinin
result
viru
entri
inhibit
quercitrin
rhamnosid
deriv
quercetin
found
inhibit
initi
stage
viral
replic
influenza
viru
evid
decreas
mrna
synthesi
viru
studi
also
conclud
quercitrin
unabl
interact
directli
viru
particl
quercetin
shown
inactiv
helicas
proteas
hepat
c
viru
hcv
quercetin
also
block
viral
bind
entri
herp
simplex
viru
hsv
drugresist
canin
kidney
mdck
cell
anoth
flavonoid
deriv
abl
protect
mice
ebola
viru
infect
given
prior
viru
challeng
howev
mechan
flavonoid
inhibit
viral
entri
unclear
similar
manner
sulfat
rutin
shown
block
entri
human
immunodefici
virus
hiv
without
interact
host
cell
membran
cell
fusion
entri
assay
reveal
sulfat
rutin
could
drastic
inhibit
infect
cell
treat
earli
adsorpt
phase
probabl
mechan
propos
investig
inhibit
hiv
glycoproteinmedi
cellcel
fusion
step
studi
identifi
sulfat
rutin
could
also
inhibit
hsv
mechan
inhibit
still
unknown
apigenin
report
antivir
hcv
host
factor
modul
caus
reduct
matur
product
regul
hcv
infect
vitro
baicalin
found
interfer
interact
envelop
protein
host
immun
cell
antihiv
activ
achiev
inhibit
envelop
glycoprotein
mediat
fusion
cell
monocyt
express
addit
baicalin
also
report
inhibit
dengu
viru
virucid
mechan
block
attach
vero
cell
show
activ
viru
entri
stage
baicalin
abl
induc
product
interferongamma
natur
killer
nk
cell
vitro
influenza
viru
infect
suggest
baicalin
abl
directli
bind
rna
bind
domain
main
mediat
downregul
induct
trigger
immun
system
activ
janu
kinasesign
transduc
activ
transcript
protein
pathway
led
express
gene
express
gene
signal
pathway
facilit
reduct
viral
load
immun
modul
baicalein
parent
compound
baicalin
also
report
antivir
japanes
enceph
viru
jev
postul
baicalein
inhibit
jev
probabl
interact
structur
protein
viru
prevent
entri
viru
cell
howev
antivir
mechan
identifi
replic
inhibit
silico
interact
viral
protein
flavonoid
genistein
ginkgetin
report
inhibit
assembl
releas
hiv
influenza
viru
respect
genistein
inhibit
vpu
protein
involv
format
ion
channel
infect
cell
thu
control
releas
hiv
ginkgetin
inhibit
sialidas
activ
influenza
viru
thu
inhibit
viru
assembl
releas
fisetin
possess
postinfect
antichikv
activ
inhibit
ns
protein
dosedepend
manner
moreov
observ
chikv
protein
precursor
also
downregul
treatment
fisetin
similarli
decreas
replic
process
observ
vero
cell
treat
fisetin
infect
postul
antivir
activ
could
due
direct
bind
fisetin
viral
rna
thu
imped
polymeras
activ
kaempferol
structur
flavonol
deriv
studi
identifi
suitabl
pharmacophor
design
antivir
influenza
viru
studi
reveal
flavonol
structur
similar
kaempferol
abl
noncompetit
inhibit
neuraminidas
enzym
howev
exact
interact
partner
still
unknown
moreov
kaempferol
also
report
inhibit
channel
coronaviru
block
releas
viru
progeni
luteolin
found
interfer
entri
influenza
viru
sever
acut
respiratori
syndrom
coronaviru
sarscov
interact
hemagglutinin
influenza
viru
protein
sar
cov
virus
respect
anoth
group
flavonoid
viz
methoxyflavon
isoscutellarein
report
inhibit
earli
replic
influenza
viru
reduct
sialidas
activ
inhibit
lysosom
fusion
rna
polymeras
activ
naringenin
flavanon
also
possess
antivir
activ
hcv
chikv
replic
inhibit
rna
protein
level
flavonoid
silymarin
broadspectrum
antivir
activ
abl
block
entri
fusion
hcv
viral
pseudoparticl
pp
cell
pretreat
silymarin
moreov
shown
interfer
replic
process
denv
chikv
influenza
viru
tea
catechin
also
report
inhibit
influenza
viru
bind
hemagglutinin
restrict
viru
adsorpt
prevent
penetr
viru
cell
tea
catechin
studi
clinic
trial
matsumoto
cowork
conduct
random
control
trial
studi
effect
tea
catechin
prevent
influenza
viru
infect
healthcar
worker
elderli
home
tea
catechin
effect
prevent
clinic
incid
influenza
infect
treatment
group
compar
placebo
group
epigallocatechin
egc
tea
catechin
flavonoid
report
inhibit
replic
influenza
b
virus
vitro
acidif
lysosom
endosom
environ
clathrinmedi
endocytosi
apart
antivir
activ
influenza
viru
anoth
flavonoid
tea
catechin
epigallocatechin
gallat
egcg
shown
directli
bind
tcell
bind
block
bind
envelop
protein
caus
viral
entri
inhibit
egcg
also
demonstr
bind
glycoprotein
b
glycoprotein
hsv
render
noninfect
moreov
egcg
shown
potent
antivir
activ
chikv
block
entri
probabl
compet
cellular
coreceptor
target
cell
heparan
sulfat
sialic
acid
egcg
also
found
inhibit
replic
viru
ebv
inhibit
zta
rta
ead
gene
inhibit
interrupt
signal
pathway
lytic
cycl
ebv
egcg
also
inhibit
hepat
b
viru
hbv
replic
impair
product
precor
mrna
replic
intermedi
dna
zika
viru
also
inhibit
egcg
abl
interact
lipid
envelop
block
entri
viru
cell
also
caus
acidif
lysosom
make
unfavor
environ
viru
replic
antivir
activ
sever
flavonoid
accord
mechan
inhibit
variou
virus
summar
tabl
structur
flavonoid
found
supplementari
materi
tabl
molecular
structur
antivir
flavonoid
picornavirus
nonenvelop
rna
virus
belong
picornavirida
famili
natur
host
vertebr
reptil
fish
amphibian
bird
mammal
viral
infect
poliomyel
hepat
common
cold
hand
foot
mouth
diseas
caus
picornavirus
flavonoid
particular
shown
promis
result
laboratori
picornavirus
flavonoid
discuss
quercetin
wellstudi
flavonoid
exhibit
antirhinovir
rv
activ
inhibit
viral
transcript
translat
process
quercetin
decreas
endocytosi
rv
reduc
phosphoryl
akt
effector
phosphoinositol
epitheli
cell
pretreat
quercetin
addit
also
reduc
viral
infect
ad
h
postinfect
vitro
moreov
also
repress
interferon
respons
result
lower
viral
rna
capsid
protein
product
quercetin
demonstr
similar
effect
vivo
decreas
viral
load
suppress
viral
immun
mediat
quercetin
shown
protect
mice
challeng
quercetintr
mengo
viru
interest
note
antivir
activ
detect
quercetin
test
cell
observ
led
studi
role
interferon
induct
antivir
activ
howev
signific
detect
interferon
drugtreat
mice
result
specul
antivir
activ
achiev
macrophag
activ
instead
interferon
induct
studi
quercetin
also
found
inhibit
encephalomyocard
viru
emcv
macrophag
activ
methyl
deriv
quercetin
shown
inhibit
polioviru
block
synthesi
viral
genom
rna
protein
similarli
trimethylquercetin
shown
inhibit
product
progeni
coxsackieviru
protect
mice
death
upon
lethal
challeng
anoth
independ
studi
dihydroquercetin
isol
larix
sibirica
found
mediat
vivo
infect
inhibit
ro
induc
oxid
stress
similarli
luteolin
deriv
studi
picornavirus
exampl
luteolin
found
inhibit
rna
synthesi
coxsackieviru
moreov
also
report
inhibit
polioviru
replic
stage
howev
mechan
inhibit
polioviru
luteolin
still
unknown
contrast
luteolin
deriv
eupafolin
shown
inhibit
inhibit
viral
attach
shown
reduc
rant
led
inactiv
virusinduc
upregul
cjun
signal
pathway
similar
manner
kaemferol
deriv
also
identifi
potent
inhibitor
picornavirus
methylkaempferol
report
inhibit
late
replic
step
polioviru
inhibit
mechan
attribut
potenti
flavonoid
inhibit
positivestrand
synthesi
viral
rna
furthermor
deriv
identifi
replic
inhibitor
rhinoviru
coxsackieviru
vitro
group
methoxi
flavon
report
inhibit
downregul
signal
pathway
apoptosi
furthermor
entri
rhinoviru
shown
inhibit
silico
inhibit
protein
grid
viru
anoth
flavonoid
sakuranetin
also
identifi
potent
inhibitor
antioxid
properti
sever
flavonoid
report
inhibit
activ
variou
picornavirus
howev
exact
molecular
mechan
action
still
unknown
exampl
bioflavonoid
variou
chemic
class
exhibit
antivir
activ
picornavirus
summar
tabl
structur
flavonoid
found
supplementari
materi
tabl
molecular
structur
antivir
flavonoid
apigenin
flavon
test
antivir
potenti
fuyang
brcr
strain
abl
reduc
infect
inhibitori
concentr
apigenin
inhibit
infect
suppress
viral
intern
ribosom
entri
site
ire
activ
apigenin
found
disrupt
viral
rna
associ
hnrnp
protein
moreov
apigenin
found
inhibit
cellular
apoptosi
cleavag
consid
prime
process
releas
viral
progeni
also
known
scaveng
reactiv
oxygen
speci
ro
found
reduc
infectioninduc
ro
gener
damag
cell
furthermor
decreas
cytokin
level
involv
infect
apigenin
confirm
inhibit
activ
cjun
ntermin
kinas
jnk
pathway
requir
replic
process
releas
progeni
anoth
downstream
map
kinas
signal
pathway
found
partial
inhibit
apigenin
inhibitori
mechan
suggest
suppress
viral
infect
recent
studi
dai
et
al
apigenin
exhibit
potent
antivir
activ
genotyp
strain
vitro
vivo
abl
reduc
cytopath
effect
concentr
cell
moreov
apigenin
significantli
reduc
viral
rna
protein
synthesi
vitro
evalu
potenti
protect
newborn
balbc
mice
intracrani
lethal
challeng
apigenin
found
protect
mice
dose
mgkg
surviv
rate
signific
improv
clinic
score
bodi
mass
also
observ
treatment
group
compar
control
group
baicalin
flavon
report
inhibit
brcrtr
strain
postinfect
assay
baicalin
shown
inhibit
viral
infect
h
postinfect
inhibit
baicalin
earli
stage
infect
due
decreas
mrna
protein
level
polymeras
moreov
also
demonstr
baicalin
reduc
express
fasl
henc
inhibit
induc
apoptosi
rhabdomyosarcoma
cell
rd
addit
identifi
inhibit
proinflammatori
cytokin
reduct
express
chrysin
flavon
wide
found
leav
fruit
veget
chrysin
ester
diisopropyl
phosphat
evalu
clinic
isol
found
inhibit
viral
replic
process
block
activ
protein
chrysin
ester
found
potent
inhibitor
protein
parent
chrysin
activ
predict
silico
simul
confirm
vitro
proteas
inhibit
assay
flavonoid
abl
decreas
product
viral
capsid
infecti
virion
rna
fisetin
flavonol
report
possess
antivir
activ
clinic
isol
fisetin
abl
inhibit
enzymat
activ
recombin
proteas
viru
cellbas
assay
confirm
activ
vitro
antivir
assay
perform
rd
cell
fisetin
found
block
cleavag
activ
therebi
inhibit
viral
replic
isoflavon
formononetin
test
sever
isol
includ
brcr
h
shzh
inflammatori
pathway
erk
jnk
mapk
usual
upregul
infect
help
viral
reproduct
formononetin
shown
act
mapk
pathway
reduc
activ
downstream
regul
infectioninduc
inflamm
mediat
prostaglandin
cyclooxygenas
turn
reduc
viral
infect
moreov
also
suppress
signal
cascad
erk
jnk
pathway
bring
infect
anoth
studi
formononetin
found
inhibit
strain
formononetin
abl
inhibit
attach
entri
vero
cell
evalu
exact
target
viru
passag
increas
concentr
formononetin
sequenc
passag
common
mutat
caus
observ
mutat
abl
confer
viral
resist
toward
formononetin
resist
confirm
absenc
mutat
wild
type
viru
mutant
viru
evalu
attach
vero
cell
mutat
found
inhibit
viral
attach
hypothes
formononetin
could
possibl
caus
overal
conform
chang
viral
capsid
formononetin
also
evalu
antivir
potenti
subgenotyp
strain
cell
exhibit
antivir
activ
significantli
reduc
viral
replic
protein
synthesi
also
protect
newborn
mice
surviv
rate
significantli
improv
clinic
score
anim
bodi
weight
dose
mgkg
hydroxyflavon
synthet
molecul
core
structur
also
backbon
flavonol
wang
et
al
predict
phosphat
ester
phosphat
abl
inhibit
activ
proteas
silico
evalu
vitro
potenti
flavonoid
antivir
isol
found
phosphat
inhibit
virusinduc
cytopath
effect
rd
cell
respect
addit
flavonoid
significantli
reduc
viral
protein
synthesi
flavonol
kaempferol
report
inhibit
clinic
isol
kaempferol
treat
cell
observ
reduc
viru
yield
log
unit
hpi
kaempferol
abl
exert
action
induct
transfactor
far
upstream
elementbind
protein
fubp
hnrp
transfactor
identifi
bind
highli
conserv
utr
region
viru
genom
attenu
viral
infect
moreov
also
disrupt
activ
ire
overal
chang
composit
transfactor
result
reduc
viral
infect
inhibit
translat
replic
kaempferol
found
inhibit
subgenotyp
strain
significantli
reduc
rna
copi
number
protein
synthesi
hpi
newborn
balbc
mice
also
protect
lethal
challeng
viru
mgkg
kaempferol
clinic
score
bodi
weight
found
similar
solvent
treat
group
neg
control
luteolin
one
exampl
flavonoid
act
earli
step
subgenotyp
replic
cycl
postattach
inhibit
viru
found
moreov
luteolin
test
prototyp
brcr
strain
isol
abl
prevent
virusinduc
ro
gener
cellular
apoptosi
inflammatori
cytokin
product
anoth
independ
studi
dai
et
al
show
luteolin
exhibit
similar
inhibit
pattern
identifi
reduc
viral
replic
protein
synthesi
moreov
murin
model
show
protect
newborn
mice
dose
mgkg
eupafolin
methoxi
deriv
luteolin
also
found
inhibit
independ
studi
shown
inhibit
chemokin
rant
upregul
vitro
viral
infect
inhibit
result
downregul
erk
activ
mediat
inflammatori
signal
pathway
penduletin
methyl
flavonol
abundantli
found
leav
laggera
pterodonta
compound
test
antivir
activ
strain
flavonoid
potent
inhibitor
vero
rd
cell
respect
mechanist
studi
reveal
penduletin
specif
inhibit
product
infecti
rna
viral
progeni
moreov
also
abl
reduc
express
postinfect
assay
suggest
abil
halt
protein
synthesi
viral
replic
process
penduletin
also
exhibit
potent
vitro
vivo
antivir
activ
subgenotyp
strain
found
cell
newborn
balbc
mice
surviv
lethal
challeng
mice
treat
mgkg
dose
penduletin
peracet
pulicarin
one
lessstudi
flavonoid
virus
methoxyphenyl
acet
deriv
flavonoid
found
possess
activ
recent
screen
flavonoid
librari
antivir
activ
pulicarin
associ
inhibit
polymeras
express
replic
process
prunin
flavanon
glycosid
recent
found
potent
antivir
enterovirus
b
includ
clinic
isol
strain
h
genotyp
prunin
abl
suppress
activ
ire
disrupt
protein
rna
synthesi
nm
evalu
murin
model
use
newborn
balbc
mice
prunin
abl
protect
lethal
challeng
strain
surviv
rate
dose
mgkg
mgkg
per
mice
apart
suppress
ire
activ
vitro
prunin
success
protect
mice
infiltr
immun
cell
inflamm
tissu
moreov
prunin
also
abl
reduc
viral
antigen
hindlimb
muscl
mice
quercetin
found
possess
broadspectrum
antivir
activ
sever
mechan
test
quercetin
abl
target
postattach
stage
infect
vitro
disrupt
viral
rna
anoth
studi
quercetin
predict
interact
catalyt
residu
proteas
could
inhibit
activ
viral
proteas
silico
confirm
find
quercetin
evalu
antivir
activ
use
isol
observ
vero
cell
rd
cell
quercetin
also
investig
antiapoptot
potenti
virusinduc
cell
death
quercetin
abl
prevent
viral
spread
induc
apoptosi
thu
make
dual
action
antivir
agent
rutin
anoth
glycosid
flavonol
deriv
quercetin
identifi
antivir
use
recombin
proteas
screen
assay
confirm
activ
vitro
rutin
test
strain
rutin
abl
inhibit
replic
stage
infect
anoth
studi
rutin
found
reduc
infect
subgenotyp
anticip
mechan
recogn
suppress
signal
pathway
direct
inhibit
proteas
interfer
inflammatori
pathway
assum
contribut
reduct
viru
titr
quercetagetin
synthet
deriv
quercetin
identifi
inhibit
rna
replic
machineri
viral
translat
flavonoid
found
reduc
activ
polymeras
vitro
similarli
chrysosplenetin
methyl
deriv
quercetagetin
identifi
potent
inhibit
reduc
product
viral
rna
protein
quercetin
methoxi
deriv
isorhamnetin
chrysosplenetin
evalu
vitro
vivo
potenti
antivir
subgenotyp
quercetin
chrysosplenetin
display
potent
antivir
activ
vitro
respect
isorhamnetin
show
inhibit
three
flavonoid
reduc
rna
protein
synthesi
vitro
studi
flavonoid
evalu
identifi
protect
effect
mice
lethal
challeng
isorhamnetin
found
confer
best
protect
dose
mgkg
surviv
quercetin
could
protect
anim
use
dose
despit
potent
antivir
amongst
three
flavonoid
test
vitro
chrysosplenetin
least
effect
vivo
anim
surviv
treatment
mgkg
chrysosplenetin
three
flavonoid
abl
improv
clinic
score
bodyweight
treat
anim
taken
consider
studi
rout
viru
inocul
intracrani
flavonoid
administ
intraperiton
ip
rout
differ
inject
rout
could
result
vari
efficaci
flavonoid
cross
bloodbrain
barrier
potenti
protect
mice
viru
vivo
antivir
activ
differ
flavonoid
summar
tabl
flavon
deriv
mosloflavon
norwogonin
oroxylin
abund
scutellaria
baicalensi
georgi
flavon
isol
pure
compound
report
inhibit
earli
stage
replic
respect
three
flavonoid
abl
limit
replic
process
lead
inhibit
viral
protein
synthesi
howev
oroxylin
found
possess
superior
activ
compar
mosloflavon
norwogonin
furthermor
flavonoid
evalu
potenti
inhibit
viral
attach
entri
none
flavonoid
found
involv
inhibit
attach
entri
viru
vero
cell
exampl
flavonoid
report
inhibit
howev
mechan
modul
infect
still
unknown
exampl
includ
nobiletin
morin
hydrat
myricetin
taxifolin
diosmetin
dihydromyricetin
hesperidin
thio
flavon
galangin
flavonoid
class
differ
variou
substitut
particularli
phenol
hydroxyl
oh
group
flavan
nucleu
flavonoid
success
account
antivir
activ
mostli
belong
flavonoid
subclass
flavonol
flavon
flavon
dual
fuse
aromat
ring
c
extens
benzen
ring
b
posit
ring
c
figur
skeleton
ring
fuse
ring
c
previous
report
possess
antivir
activ
dengu
viru
complex
moreov
hydroxyl
ring
particularli
posit
found
favor
antivir
activ
influenza
viru
base
previou
find
expect
structur
could
attribut
toward
antivir
activ
observ
flavonoid
methyl
drastic
improv
antivir
activ
case
chrysosplenetin
eupafolin
penduletin
prune
tabl
moreov
presenc
methoxi
substitut
posit
ring
along
hydroxyl
methoxi
group
posit
render
higher
activ
lowest
valu
chrysosplenetin
eupafolin
penduletin
amongst
evalu
flavonoid
prunin
glucosid
naringenin
larg
glucos
moieti
posit
instead
methoxi
substitut
interestingli
show
potent
antivir
activ
well
exampl
specul
posit
ring
requir
bulki
group
substitut
order
possess
potent
activ
possibl
interact
differ
substitut
could
studi
silico
determin
natur
bond
involv
antivir
activ
must
note
antivir
activ
flavonoid
evalu
specif
genotypesubgenotyp
unknown
broad
spectrum
antivir
activ
genotypessubgenotyp
flavonoid
abund
fruit
veget
therefor
consid
safe
nontox
human
consumpt
howev
bioavail
flavonoid
crude
form
poor
use
isol
purifi
chemic
synthes
small
molecular
weight
flavonoid
increas
prospect
reach
target
enhanc
stabil
solubl
improv
system
distribut
nanodrug
deliveri
system
employ
despit
possess
potenti
treat
vitro
mice
flavonoid
fail
reach
clinic
trial
possibl
reason
could
includ
infanc
vivo
studi
flavonoid
two
report
publish
claim
absolut
protect
mice
prunin
isorhamnetin
moreov
lack
longterm
toxic
data
purifi
flavonoid
contribut
challeng
progress
potenti
molecul
clinic
trial
anoth
import
factor
could
develop
resist
mutant
virus
flavonoid
like
drug
candid
purifi
flavonoid
requir
regulatori
approv
food
drug
administr
fda
market
antivir
detail
pharmacokinet
pharmacodynam
longterm
toxicolog
studi
flavonoid
necessari
offer
therapeut
option
flavonoid
penduletin
eupafolin
baicalin
luteolin
quercetin
chrysosplenetin
shown
antivir
agent
base
valu
flavonoid
also
found
safe
noncytotox
human
cell
indic
valu
flavonoid
prunin
could
confer
protect
neonat
mice
luteolin
show
protect
lethal
challeng
howev
flavonoid
higher
valu
also
serv
potenti
antivir
instanc
kaempferol
isorhamnetin
exhibit
higher
vitro
confer
signific
protect
mice
viral
challeng
flavonoid
yet
test
vivo
could
evalu
identifi
effect
flavonoid
abil
target
variou
stage
viral
infect
becom
focus
topic
explor
potenti
antivir
current
era
apart
classic
antioxid
properti
flavonoid
shown
inhibit
virus
molecular
level
vitro
vivo
light
current
find
vivo
efficaci
flavonoid
conclud
flavonoid
great
potenti
develop
therapeut
candid
howev
make
flavonoid
avail
antivir
depth
understand
pharmacolog
properti
clinic
outcom
warrant
